Ann: Shareholder Update , page-29

Medimmune is another one - 15 months & nothing more than the occasional line snuck in somewhere ?

You'd think collaborations would get atleast a yearly upate (outside of the Annual Report) on it's progression right ? Partner specific updates is what you want to see.


PHYLOGICA ADVANCES COLLABORATION IN MEDIMMUNE ANTIBIOTIC DISCOVERY PARTNERSHIP

PERTH, AUSTRALIA: November 21, 2011 –

Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the progression of its collaboration with MedImmune, the worldwide biologics unit of AstraZeneca, to develop novel antibiotics. Phylogica and MedImmune entered into the collaboration in August 2010 to evaluate Phylogica’s proprietary Phylomer® platform to identify antimicrobial peptides for infectious disease. The joint research programme is on track and Phylogica has recently completed the methods validation and progressed to the final stage of the Research Plan with its Phylomer-based constructs.